An HIV vaccine under development in the United States proved safe, but did not offer protection against contracting the human immunodeficiency virus, and was therefore discontinued, according to a statement issued by the National Institute of Health (NIH), Xinhua and UPI report, Agerpres reads. The late-stage clinical trial, titled HPX3002/HVTN 706 or „Mosaico,” began in […]
An HIV vaccine under development in the United States proved safe, but did not offer protection against contracting the human immunodeficiency virus, and was therefore discontinued, according to a statement issued by the National Institute of Health (NIH), Xinhua and UPI report, Agerpres reads. The late-stage clinical trial, titled HPX3002/HVTN 706 or „Mosaico,” began in […]
